The most prominent change was the CLint of CYP2C8, which in HCC patients was 77% that of the value for the controls (0.63 vs. 2.7μl/min/mg, respectively; P < 0.01). The gene discussed is CYP2C8; the disease is hepatocellular carcinoma.